Charles B. Eaton MD, MS
Eaton MD CB. Combination candesartan–HCTZ did not reduce major CV events in patients at intermediate CV risk. Ann Intern Med. 2016;165:JC7. doi: 10.7326/ACPJC-2016-165-2-007
Download citation file:
Published: Ann Intern Med. 2016;165(2):JC7.
Cardiology, Coronary Risk Factors, Hypertension, Nephrology, Prevention/Screening.
Results provided by:
Copyright © 2018 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use